Results from SCHOLAR-1 trial for DLBCL patients
Results from SCHOLAR-1 trial for DLBCL patients
PD-1 enhances elotuzumab efficacy
Better screening programmes needed for haematological malignancies such as leukaemia
Chemo-genomic interrogation reveals JAK sensitive subgroup in AML
The role of AKT in chronic lymphocytic leukaemia transformation to Richter's syndrome
Targeted genome editing in haematopoeitic stem cells
Risk adapted therapy for acute myeloid leukaemia
Clinical characteristics and prognostic factors of plasmablastic lymphoma patients
Recent developments in targeted therapies
MyPathway guidance of targeted therapy based on molecular profiles
Patient engagement in The Metastatic Breast Cancer Project
Editor's Choice for May 2016